Evidence map›Paper›PMID 28510026›Full record

ReviewBiophysical reviews2009

Gene electrotransfer: from biophysical mechanisms to in vivo applications : Part 2 - In vivo developments and present clinical applications.

Jean-Michel Escoffre, Chloé Mauroy, Thomas Portet, Luc Wasungu, Aurelie Paganin-Gioanni, Muriel Golzio, Justin Teissié, Marie-Pierre Rols

Abstract readReview
In one paragraph

Review in Biophysical reviews, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jean-Michel EscoffreCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Université de Toulouse UPS, 205 route de Narbonne, 31077, Toulouse, France.
Chloé MauroyCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Université de Toulouse UPS, 205 route de Narbonne, 31077, Toulouse, France.
Thomas PortetCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Université de Toulouse UPS, 205 route de Narbonne, 31077, Toulouse, France.
Luc WasunguCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Université de Toulouse UPS, 205 route de Narbonne, 31077, Toulouse, France.
Aurelie Paganin-GioanniCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Université de Toulouse UPS, 205 route de Narbonne, 31077, Toulouse, France.
Muriel GolzioCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Université de Toulouse UPS, 205 route de Narbonne, 31077, Toulouse, France.
Justin TeissiéCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Université de Toulouse UPS, 205 route de Narbonne, 31077, Toulouse, France. justin.teissie@ipbs.fr.
Marie-Pierre RolsCNRS, IPBS (Institut de Pharmacologie et de Biologie Structurale), Université de Toulouse UPS, 205 route de Narbonne, 31077, Toulouse, France. rols@ipbs.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gene electrotransfer can be obtained not just on single cells in diluted suspension. For more than 10 years, this is a quasi routine strategy in tissue on the living animal and a few clinical trials have now been approved. New problems have been brought by the close contacts of cells in tissue both on the local field distribution and on the access of DNA to target cells. They need to be solved to provide a further improvement in the efficacy and safety of protein expression. There is a competition between gene transfer and cell destruction. Nevertheless, present results are indicative that electrotransfer is a promising approach for gene therapy. High level and long-lived expression of proteins can be obtained in muscles. This is used for a successful method of electrovaccination.

Indexed as

ElectropermeabilizationElectroporationGene electrotransferIn vivo applications

Identifiers

PMID28510026
PMCPMC5418385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.